Hep Email Update Hepatitis C Treatment Rate Remains Low, Despite Efficacy Even though as many as 97% of patients can be cured with medication, many still don’t receive the treatment. Most Reported Substance Use Among Adolescents Held Steady in 2022 In 2022, reported use of any illicit drug within the past year remained at or significantly below pre-pandemic levels for all grades. Resmetirom Improved Liver Fat and Fibrosis in Late-Stage NASH Trial Positive results announced in a Madrigal press release could potentially lead to the first drug approval for fatty liver disease. Advertisement Study Finds Hepatitis C Treatment Gap for Individuals With Alcohol Use Disorder Current guidelines recommend antiviral treatment regardless of alcohol use. Alcohol-Related Liver Disease Rose Sharply During the Pandemic Women and young adults saw especially large increases between 2019 and 2021. Hep A Outbreaks Our map outlines where in the United States active cases of hepatitis A have been reported in the past 12 months on a scale from 0 to 100 relative to other states. Advertisement Science News Resmetirom Improved Liver Fat and Fibrosis in Late-Stage NASH Trial Alcohol-Related Liver Disease Rose Sharply During the Pandemic Study Finds Hepatitis C Treatment Gap for Individuals With Alcohol Use Disorder Children’s Hepatitis Outbreak Still Lacks Definitive Answers Newsfeed Haven’t Seen Your Doctor in a Few Years? You May Need to Find a New One Hepatitis C Treatment Rate Remains Low, Despite Efficacy Most Reported Substance Use Among Adolescents Held Steady in 2022 Employers Use Patient Assistance Programs to Offset Their Own Costs Science News Resmetirom Improved Liver Fat and Fibrosis in Late-Stage NASH Trial Alcohol-Related Liver Disease Rose Sharply During the Pandemic Study Finds Hepatitis C Treatment Gap for Individuals With Alcohol Use Disorder Children’s Hepatitis Outbreak Still Lacks Definitive Answers Newsfeed Haven’t Seen Your Doctor in a Few Years? You May Need to Find a New One Hepatitis C Treatment Rate Remains Low, Despite Efficacy Most Reported Substance Use Among Adolescents Held Steady in 2022 Employers Use Patient Assistance Programs to Offset Their Own Costs

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: